RB
Remedium Bio Inc.
SEC filingBiotechnology · Needham, MA
Amount raised$1.5Msold at filing
Total offering$10M$8.5M still open
Investors in the raise1count reported to the SEC
FiledMay 18, 2026first sale May 6, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Alexei GoraltchoukExecutive Officer, Director
Frank LuppinoExecutive Officer, Director
Harry RobbDirector
Richard HagueDirector
Executive officers, directors and promoters as listed on the Form D.